NCT07719309

Brief Summary

The purpose of this exploratory study is to obtain preliminary data on peristomal and non-peristomal skin barrier characterisation in people living with a stoma. The main questions it aims to answer are:

  • Is there a difference/similarity in skin barrier characterisation of peristomal and non-peristomal skin in people living with a stoma?
  • Is there a difference/similarity in peristomal skin barrier function of different stoma types (colostomy, ileostomy and urostomy)?
  • Does a stoma type/function, influence skin barrier characterisation of peristomal skin? Participants will:
  • Attend a 1-hour study appointment
  • Undergo non-invasive skin procedures

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

1.7 years

First QC Date

July 14, 2026

Last Update Submit

July 17, 2026

Conditions

Keywords

Peristomal skinSkin Barrier CharacterisationPeople Living with a StomaExploratory StudyPeristomal Skin Health

Outcome Measures

Primary Outcomes (3)

  • Assessment description of skin microbial composition of peristomal and non-peristomal skin

    Each participant will provide four skin swab samples for microbiome profiling: two swabs from the peristomal (experimental) test site area and two swabs from the non-peristomal (control) test site area, on the opposite side of the abdomen. To Identify microbial species, present in peristomal and non-peristomal area using Metagenomic Shotgun Sequencing

    Study appointment (1 hour)

  • Assessment of skin barrier chemical composition including water (mass-%), ceramides & fatty acids urea, lactate, protein, natural moisturising factors (NMF) and stratum corneum (SC) thickness of peristomal and non-peristomal skin

    6 High Wavenumber profiles of water (mass%) and SC thickness (Microns) and 6 Fingerprint profiles of ceramides \& fatty acids urea, lactate, protein and natural moisturising factors (NMF) from peristomal skin (experimental) test site area and non-peristomal (control) skin test site area, using the Raman spectrometer

    Study Appointment (1 hour)

  • Biophysical skin properties including Transepidermis water loss (TEWL), redness and skin colour, elasticity, sebum and pH of peristomal and non-peristomal skin

    Measurement of Transepidermal water loss (TEWL) with Tewameter, skin colour (melanin) and skin redness (erythema) with Mexameter, elasticity and firmness with Cutometer, sebum level with Subumeter and pH with pH Meter from peristomal area (experimental) skin test and non-peristomal (control) skin test area

    Study Appointment (1 hour)

Secondary Outcomes (3)

  • Compare microbiota analysis of each peristomal skin stoma type (Colostomy, Ileostomy and Urostomy)

    Study Appointment (1 hour)

  • Compare skin barrier chemical composition including water (mass-%), ceramides & fatty acids urea, lactate, protein, natural moisturising factors (NMF) and stratum corneum (SC) thickness of each stoma type peristomal skin

    Study Appointment (1 hour)

  • Compare biophysical skin properties including Transepidermis water loss (TEWL), redness and skin colour, elasticity, sebum and pH of stoma type (Colostomy, Ileostomy and Urostomy) peristomal skin

    Study Appointment (1 hour)

Other Outcomes (1)

  • Correlation between peristomal skin barrier characterisation and stoma type/function and management

    Study Appointment (1 hour)

Study Arms (1)

People Living with a Stoma

Colostomy, Ileostomy, Urostomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be recruited from Birmingham UK and the surrounding areas (up to a distance of 150 miles)

You may qualify if:

  • Adult 18 years or over
  • Have a stoma (colostomy, ileostomy or urostomy)
  • Have healthy peristomal skin
  • Have the ability to provide informed consent
  • Are independently mobile
  • Can stop using any stoma paste, cream, sprays or lotions on peristomal skin 1 day (24hrs) prior to the study appointment
  • Are independent with stoma care management
  • Are able to attend study appointment in Birmingham, UK

You may not qualify if:

  • Have a current skin condition, such as eczema, psoriasis, or infection around the skin test site areas
  • Have bleeding or broken peristomal skin
  • Are currently taking any of the following medications: steroids, nicotine patches, acne medication (e.g., Accutane), any medication know to affect the properties of the skin
  • Use patches on your abdomen, such as HRT patches
  • Are receiving or have had radiotherapy or chemotherapy in the last 2 months
  • Are taking or have had antibiotic treatment in the last 4 weeks
  • Are currently receiving any stoma care treatment under a stoma care nurse specialist
  • Have tattoos in the skin test site areas
  • Are pregnant
  • Have excessive hair on your abdomen
  • Have participated in another skin testing study within the last 8 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salts Healthcare

Birmingham, B7 4AA, United Kingdom

Location

Study Officials

  • Mireille Hamson

    Salts Healthcare

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mireille Hamson

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 22, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

July 22, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations